地瑞那韋/達蘆那韋

ChemLeader 98+%

Darunavir (TMC114)

產品編號：CL2205 CAS No.：206361-99-1 MDLNo： 分子式：C??H??N?O?S 分子量：547.66

加入收藏分享給朋友

規格	庫存	目錄價	會員專享價	數量
200 mg	In-stock	￥300.00	登錄后可見	- +
500 mg	In-stock	￥450.00	登錄后可見	- +
1 g	In-stock	￥750.00	登錄后可見	- +
5 g	In-stock	￥3000.00	登錄后可見	- +

化學品安全說明書(MSDS)

下載MSDS

質檢證書(COA)

下載COA

發送詢價加入購物車

基本信息
相關文檔
產品詳情
相關文獻

基本信息

英文名稱	Darunavir (TMC114)
中文名稱	地瑞那韋/達蘆那韋
CAS號	206361-99-1
分子式	C??H??N?O?S
分子量	547.66
外觀	White to off-white powder
儲存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產品詳情

Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions and also inhibits the dimerization of HIV-1 protease suppressing proteolytic activity and subsequent replication of HIV-1. Study results have shown that darunavir exhibits potent inhibition against HIV-1 with a value of 50% inhibition concentration IC50 of 0.003 μmol/L in HIV-1 infected MT-2 cells. Darunavir binds to HIV-1 protease with considerably high affinity and fits closely with the substrate envelop leading to its potent ability to inhibit multidrug-resistant HIV strains. Prezista is an OARAC recommended treatment option for treatment-na?ve and treatment-experienced adults and adolescents.

相關文獻

抱歉，暫時沒有相關文獻

相關產品

抱歉，暫時沒有相關產品

瀏覽記錄

CL2205

地瑞那韋/達蘆那韋

206361-99-1 98+% In-stock

￥300.00 200 mg